Genetic Disorder Samples
The category Genetic Disorder Samples comprises the subgroups Congenital Disorder Samples and Tumor Disease Samples. You can use our filter functions to perform complex searches according to laboratory parameters such as Lactate dehydrogenase, Cancer-Antigen 125, Protein S-100, Cancer-Antigen 19-9 or Prostate specific antigen, ICD-10 code, donor age and gender as well as medication. For normal control groups please switch to the category Healthy Donors. Procurement takes place from consented donors under strict ethical standards. If you do not find the research samples you are looking for, please contact us.
26,955 Products
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Female Age: 84
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
- Medication:
- Actrapid
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Female
- Age:
- 84 Years
- BMI:
- 26.7 kg/m²
- Weight:
- 65 kg
- Height:
- 156 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
- Actrapid
- Carmen
- Moxonidin
- Protaphane
- acetylsalicylic acid (ASA) (Dosages: 100not specified)
- bisoprolol (Dosages: 2not specified)
- hydrochlorothiazide (HCT) (Dosages: 25mg)
- insulin
- omeprazole (Dosages: 20mg)
- simvastatine (Dosages: 20mg)
- valsartan (Dosages: 160mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 154.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490049
Quant: 94.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.95 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 12.70 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 285.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 115.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 35.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 10.40 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 67.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289549
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2
- Donor:
- Gender: Female Age: 72
- Diagnosed disease:
- C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
- Medication:
- Candesartan/candesartan
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Female
- Age:
- 72 Years
- BMI:
- 26.6 kg/m²
- Weight:
- 68 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
- Candesartan/candesartan (Dosages: 16mg)
- Digimerck
- acetylsalicylic acid (ASA) (Dosages: 103not specified)
- bisoprolol (Dosages: 5mg)
- ciprofloxacin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 161.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 26.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 10.70 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 33.70 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 105.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 79.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 163.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490069
Quant: 20.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 11.60 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 29.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307943
0.9 mL ($38.81)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Female Age: 59
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
- Medication:
- Addel
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
- Gender:
- Female
- Age:
- 59 Years
- BMI:
- 24.8 kg/m²
- Weight:
- 70 kg
- Height:
- 168 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
- Addel
- Aminoven
- Cernevit
- L-thyroxine
- Meronem
- Pantozol
- bisoprolol
- lercanidipine
- metoclopramide
- potassium
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 283.00 U/L
Source: this donation
|
35-104 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 10.20 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 216.10 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 183.00 U/L
Source: this donation
|
Jun 42 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 61.00 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 49.00 U/L
Source: this donation
|
Okt 35 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 10.50 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 41.00 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: negative
Quant: 32.00 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL ($17.25)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Female Age: 67
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
- Medication:
- Metoprolol
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
- Gender:
- Female
- Age:
- 67 Years
- BMI:
- 24.2 kg/m²
- Weight:
- 65 kg
- Height:
- 164 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
- Metoprolol
- ciprofloxacin
- hydrochlorothiazide (HCT)
- lisinopril
- pantoprazole
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 212.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 18.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 13.22 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 8932.00 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 113.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 203.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 147.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 119.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 74.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 9.00 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 20.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307963
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas
- Medication:
- Androcur
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Female
- Age:
- 78 Years
- BMI:
- 22.8 kg/m²
- Weight:
- 62 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0]
Medication:
- Androcur (Dosages: 10mg)
- Gynokadin (Dosages: 7not specified)
- Kalinor
- Novaminsulfon
- Pantozol (Dosages: 40not specified)
- acetylsalicylic acid (ASA) (Dosages: 101not specified)
Therapy:
- material removal
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490109
Quant: 89.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 1.20 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 2.90 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: I100490109
Quant: 26.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490109
Quant: 30.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 21.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289376
1.2 mL ($51.75)
Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C24.0
- Donor:
- Gender: Female Age: 78
- Diagnosed disease:
- C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Fenistil
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb)
Donor:
- Gender:
- Female
- Age:
- 78 Years
- BMI:
- 24.3 kg/m²
- Weight:
- 67 kg
- Height:
- 166 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
- Fenistil (Fenistil dry)
- L-thyroxine (Dosages: 25not specified)
- Ramipril (Dosages: 5not specified)
- hydrochlorothiazide (HCT) (Dosages: 25not specified)
- pantoprazole (Dosages: 40not specified)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 299.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 214.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual:
Quant: 0.80 not specified
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual:
Quant: 164.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 235.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100489498
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: I100489498
Quant: 13.90 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308307
0.4 mL ($17.25)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 80
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - stage III, non-resectable (not specified)
- Medication:
- Fluvastatin
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 80 Years
- BMI:
- 27.7 kg/m²
- Weight:
- 80 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - stage III, non-resectable (not specified)
Medication:
- Fluvastatin (Dosages: 80mg)
- Metoprolol (Dosages: 47not specified)
- Moxonidin
- Telmisartan
- acetylsalicylic acid (ASA) (Dosages: 300mg)
- hydrochlorothiazide (HCT)
- lercanidipine (Dosages: 10mg)
- metamizole (Dosages: 1g)
- pantoprazole (Dosages: 40mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490095
Quant: 56.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 1.19 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 23.70 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: I100490095
Quant: 42.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490095
Quant: 41.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 14.70 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 44.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307918
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.0
- Donor:
- Gender: Male Age: 58
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Candesartan/candesartan
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Male
- Age:
- 58 Years
- BMI:
- 22.3 kg/m²
- Weight:
- 63 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
- Candesartan/candesartan (Dosages: 2mg)
- Pulmicort
- Verapamil (Dosages: 120mg)
Therapy:
- hemithyreoidectomy
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490071
Quant: 57.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.71 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 108.80 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 18.00 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490071
Quant: 36.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 47.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307939
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 56
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M1 (not specified)
- Medication:
- Lantus
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Male
- Age:
- 56 Years
- BMI:
- 23 kg/m²
- Weight:
- 68 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M1 (not specified)
Medication:
- Lantus
- Lasix (Dosages: 401not specified)
- Pantozol (Dosages: 40mg)
- fentanyl
- insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 413.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490104
Quant: 13.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 2.18 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 19.20 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 126.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: I100490104
Quant: 23.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 49.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 7.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307912
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Glutamate... - D37.70
- Donor:
- Gender: Male Age: 74
- Diagnosed disease:
- D37.70 - T2, N0, M0, stage IB, resectable (not specified)
- Medication:
- Actrapid
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 74 Years
- BMI:
- 22.5 kg/m²
- Weight:
- 69 kg
- Height:
- 175 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- D37.70
Medication:
- Actrapid
- Metoprolol (Dosages: 47not specified)
- Moxonidin (Dosages: 0.6not specified)
- Ramipril (Dosages: 5not specified)
- acetylsalicylic acid (ASA) (Dosages: 100not specified)
- insulin
- simvastatine (Dosages: 20not specified)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490116
Quant: 72.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.26 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 12.10 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 92.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 45.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490116
Quant: 36.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 10.60 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 48.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307896
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.2
- Donor:
- Gender: Male Age: 64
- Diagnosed disease:
- C25.2 - Malignant neoplasm of tail of pancreas - T4, N0, M0, stage III, non-resectable (not specified)
- Medication:
- Lantus
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Male
- Age:
- 64 Years
- BMI:
- 21.6 kg/m²
- Weight:
- 67 kg
- Height:
- 176 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of tail of pancreas [C25.2] - T4, N0, M0, stage III, non-resectable (not specified)
Medication:
- Lantus
- Metoprolol (Dosages: 47not specified)
- Nitrendipin (Dosages: 20mg)
- acetylsalicylic acid (ASA) (Dosages: 100mg)
- insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490083
Quant: 103.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.70 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 0.60 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 212.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: I100490083
Quant: 24.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 49.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 5.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289544
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.0
- Donor:
- Gender: Male Age: 75
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Clexane
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Male
- Age:
- 75 Years
- BMI:
- 31.6 kg/m²
- Weight:
- 82 kg
- Height:
- 161 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
- Clexane (active agent: Enoxaparin sodium)
- L-thyroxine
- Lantus
- Metoprolol
- Nitrendipin
- Ramipril
- Tromcardin
- hydrochlorothiazide (HCT)
- insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490013
Quant: 99.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.78 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 11.90 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 55.00 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 156.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 61.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 27.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289564
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.0
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Female
- Age:
- 64 Years
- BMI:
- 28.4 kg/m²
- Weight:
- 70 kg
- Height:
- 157 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
- L-thyroxine
- antidepressants
- metformin
- omeprazole
- paroxetine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490027
Quant: 75.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.25 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 17.50 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 24.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 175.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: I100490027
Quant: 27.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 81.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 26.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289559
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 54
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 54 Years
- BMI:
- 31.7 kg/m²
- Weight:
- 96 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
- L-thyroxine (Dosages: 100not specified)
- Lactrase
- Pantozol (Dosages: 40mg)
- Quetiapin (Dosages: 25mg)
- RamiLich (Dosages: 5mg)
- antidepressants
- fluoxetine (Dosages: 20mg, Fluoxetin Neumax)
- sedative
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 170.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490015
Quant: 37.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 16.71 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 2.50 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 239.00 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 172.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 45.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 13.80 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 79.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289563
1 mL ($43.13)
Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Hemogl... - C25.2
- Donor:
- Gender: Male Age: 82
- Diagnosed disease:
- C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M1, stage IV, non-resectable (not specified)
- Medication:
- Sortis
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Pancreatic Amylase
Donor:
- Gender:
- Male
- Age:
- 82 Years
- BMI:
- 25.3 kg/m²
- Weight:
- 73 kg
- Height:
- 170 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
- Sortis
- amlodipine
Therapy:
- transplant
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: negative
Quant: 75.00 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 407.80 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 49.00 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: negative
Quant: 24.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: negative
Quant: 31.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: I100489688
Quant: 14.70 g/dl
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: positive
Quant: 12.00 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308273
0.5 mL ($21.56)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Male Age: 69
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
- Medication:
- Fenistil
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Male
- Age:
- 69 Years
- BMI:
- 24 kg/m²
- Weight:
- 76 kg
- Height:
- 178 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
- Fenistil
- Metohexal
- Pantozol
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 314.00 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 20.90 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 993.30 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 82.00 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: positive
Quant: 114.00 mg/dl
Source: this donation
|
74 - 106 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 129.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 104.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 43.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 12.90 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 21.00 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: positive
Quant: 9.00 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308259
0.5 mL ($21.56)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Female Age: 65
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
- Medication:
- Candesartan/candesartan
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Female
- Age:
- 65 Years
- BMI:
- 21.9 kg/m²
- Weight:
- 71 kg
- Height:
- 180 cm
Sample:
- Matrix:
- Urine
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
- Candesartan/candesartan
- Pantozol
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 196.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 139.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 14.64 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 1486.00 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 86.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 89.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 55.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490111
Quant: 33.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 11.40 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 289.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307901
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.2
- Donor:
- Gender: Female Age: 61
- Diagnosed disease:
- C25.2 - Malignant neoplasm of tail of pancreas - M1, stage IV, non-resectable (not specified)
- Medication:
- Gabapentin
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Female
- Age:
- 61 Years
- BMI:
- 22.5 kg/m²
- Weight:
- 48 kg
- Height:
- 146 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of tail of pancreas [C25.2] - M1, stage IV, non-resectable (not specified)
Medication:
- Gabapentin
- Movicol
- Novamin
- Ossofortin
- Targin
- pantoprazole
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490019
Quant: 62.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.29 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 1815.00 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 68.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490019
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 13.20 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 24.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289561
1 mL ($43.13)
Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C18.6
- Donor:
- Gender: Male Age: 66 Ethnic group: European/Caucasian
- Diagnosed disease:
- C18.6 - Malignant neoplasm of descending colon
- Medication:
- Hygroton
- Parameter:
- Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
- Gender:
- Male
- Age:
- 66 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 34 kg/m²
- Weight:
- 104 kg
- Height:
- 176 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of descending colon [C18.6]
Medication:
- Hygroton (Dosages: 25mg/day, active agent: chlorthalidone)
- Metex (Dosages: 125mg/week)
- Prednisolon (Dosages: 2mg/day)
- Simvabeta (Dosages: 10mg/day)
- amlodipine (Dosages: 5mg/day)
- bisoprolol (Dosages: 5mg/day)
- hydroxychloroquine (Dosages: 400/day)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: < 8.00 IU/mL
Source: this donation
|
< 17.00 IU/mL
|
Method: not specified System: Cobas Roche |
| Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG |
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
|
< 17.00 U/mL
|
Method: ECLIA (Electro Chemiluminescence Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 27.20 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 34.37 mg/L
Source: this donation
|
< 5.00 mg/L
|
Method: not specified System: Modular Roche |
| Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) |
Qual:
Quant: 29.00 mm/1h
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 15.00 IU/mL
|
Method: TIA (Turbidimetric Immuno Assay) System: Cobas 8000 Roche |
| Total Rheumatoid Factor (tRF) |
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
|
< 14.00 IU/mL
|
Method: not specified System: Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292431
1 mL ($43.13)
Human Serum - Anti-Thyroglobulin (aTg / TAK), Thyro... - E03.9
- Donor:
- Gender: Female Age: 51 Ethnic group: European/Caucasian
- Diagnosed disease:
- C64 - left (not specified)
- Medication:
- Cimicifuga
- Parameter:
- Anti-Thyroglobulin (aTg / TAK) Thyrotropin (TSH) Thyroxine free (fT4) Triglycerides Triiodothyronine free (fT3)
Donor:
- Gender:
- Female
- Age:
- 51 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 27 kg/m²
- Weight:
- 82 kg
- Height:
- 173 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- depression
- hypothyroidism [E03.9]
- kidney cell carcinoma [C64] - left (not specified)
Medication:
- Cimicifuga (Dosages: 2/day)
- L-Thyrox (Dosages: 50µg, manufacturer: Hexal)
- Remergil (Dosages: 15mg)
- escitalopram (Dosages: 20mg)
Therapy:
- surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: 28.10 kU/L
Source: this donation
|
< 40.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: 50.85 IU/mL
Source: this donation
|
< 100.00 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Anti-Thyroglobulin (aTg / TAK) |
Qual:
Quant: 460.20 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 3.17 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine free (fT4) |
Qual:
Quant: 10.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triglycerides |
Qual: negative
Quant: 1.48 mmol/L
Source: this donation
|
< 2.25 mmol/L
|
Method: not specified System: not specified Beckman Coulter |
| Triiodothyronine free (fT3) |
Qual:
Quant: 2.70 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH341789
1 mL ($43.13)
Human Serum - 25-Hydroxy-Vitamin D3 (Calcidiol), An... - Q65.8R
- Donor:
- Gender: Male Age: 6
- Diagnosed disease:
- Q65.8R
- Parameter:
- 25-Hydroxy-Vitamin D3 (Calcidiol) Anti-Bone-specific Alkaline Phosphatase (BAP) Anti-Centromere Protein B (CENP-B) Anti-Histone Anti-Jo-1 (a-histidyl-tRNA synthetase) Anti-Mutated citrullinated Vimentin (MCV) Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Anti-Nucleosome Anti-PM-Scl Anti-Proliferating cell nuclear antigen (PCNA) ...
Donor:
- Gender:
- Male
- Age:
- 6 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Q65.8R
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| 25-Hydroxy-Vitamin D3 (Calcidiol) |
Qual: positive
Quant: 27.7 ng/mL
Source: this donation
|
30.00 - 100 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Anti-Bone-specific Alkaline Phosphatase (BAP) |
Qual: positive
Quant: 122.3 µg/L
Source: this donation
|
5.70 - 32.90 µg/L
Remarks: sex and age dependent |
Method: EIA (Enzyme Immuno Assay) System: ISYS IDS |
| Anti-Centromere Protein B (CENP-B) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Histone |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Jo-1 (a-histidyl-tRNA synthetase) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Mutated citrullinated Vimentin (MCV) |
Qual: negative
Quant: 3 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Neutrophil Cytoplasmic Antibodies (ANCA) |
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible |
negative Titer
|
Method: IIFT (Indirect Immunfluorescence Test) System: iPro EUROIMMUN AG |
| Anti-Nucleosome |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-PM-Scl |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Proliferating cell nuclear antigen (PCNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-RNP/Sm |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-SS-A (Ro) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-SS-A 52 kDa (Ro 52) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-SS-B (La) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Scl-70 (a-DNA topoisomerase I) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-Smith (Sm) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) |
Qual: negative
Quant: 5.1 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-double-stranded DNA (dsDNA) |
Qual:
Quant: low positive
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Anti-double-stranded DNA (dsDNA) |
Qual: negative
Quant: 4.7 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-ribosomal P-Protein (ARPA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Antimitochondrial Antibodies (AMA-M2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: Immunoblot System: EUROBlotMaster EUROIMMUN AG |
| Antinuclear Antibodies (ANA) |
Qual:
Quant: not specified Titer
Source: this donation
Remarks: subsequent claim possible |
negative Titer
|
Method: IIFT (Indirect Immunfluorescence Test) System: iPro ORGENTEC Diagnostika GmbH |
| Capsule-reactive protein (CRP) |
Qual: negative
Quant: 0.21 mg/L
Source: this donation
|
0.00 - 3.00 mg/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C3 |
Qual: negative
Quant: 1.12 g/L
Source: this donation
|
0.90 - 1.80 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C4 |
Qual: negative
Quant: 0.27 g/L
Source: this donation
|
0.10 - 0.40 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Osteocalcin |
Qual: positive
Quant: 93.7 ng/mL
Source: this donation
|
10.40 - 45.60 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Parathyroid hormone (PTH) |
Qual: negative
Quant: 17.7 pg/mL
Source: this donation
|
11.50 - 78.40 pg/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Rheumatoid Factor (RF) IgA |
Qual: negative
Quant: < 1.00 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgG |
Qual: negative
Quant: 3.2 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: < 1.00 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Serum Crosslaps |
Qual: positive
Quant: 2.22 ng/mL
Source: this donation
|
0.12 - 0.75 ng/mL
Remarks: sex and age dependent |
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH57509
1.2 mL ($155.25)
Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.0
- Donor:
- Gender: Female Age: 59
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas
- Medication:
- Kreon
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Female
- Age:
- 59 Years
- BMI:
- 21.4 kg/m²
- Weight:
- 50 kg
- Height:
- 153 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0]
Medication:
- Kreon (Dosages: 65000not specified)
- Pantozol (Dosages: 40mg)
- tilidine (Dosages: 5mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490047
Quant: 86.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.34 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 37.30 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 36.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 60.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 47.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490047
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 12.90 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 2773.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289550
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Female Age: 64
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M1, stage IV, non-resectable (not specified)
- Medication:
- Metoprolol
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Female
- Age:
- 64 Years
- BMI:
- 27.3 kg/m²
- Weight:
- 70 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M1, stage IV, non-resectable (not specified)
Medication:
- Metoprolol
- pantoprazole
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490031
Quant: 113.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 1.88 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 676.10 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 292.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 208.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490031
Quant: 39.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 10.60 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 32.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289557
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Glycosyla... - C25.1
- Donor:
- Gender: Female Age: 59
- Diagnosed disease:
- C25.1 - Malignant neoplasm of body of pancreas - stage III, non-resectable (not specified)
- Medication:
- Agomelatin
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
- Gender:
- Female
- Age:
- 59 Years
- BMI:
- 34.5 kg/m²
- Weight:
- 94 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of body of pancreas [C25.1] - stage III, non-resectable (not specified)
Medication:
- Agomelatin
- L-thyroxine
- antidepressants
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: I100490000
Quant: 50.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.48 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 24.30 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: negative
Quant: 19.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glucose |
Qual: negative
Quant: 98.00 mg/dl
Source: this donation
|
60 - 110 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 45.00 mmol/mol
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 14.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289567
1 mL ($43.13)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C24.0
- Donor:
- Gender: Male Age: 63
- Diagnosed disease:
- C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N0, M0, stage IIA, resectable (not specified)
- Medication:
- Candesartan/candesartan
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 63 Years
- BMI:
- 32.7 kg/m²
- Weight:
- 99 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
- Candesartan/candesartan (Dosages: 16mg)
- allopurinol
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 194.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490033
Quant: 76.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 10.30 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: negative
Quant: 20.50 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 216.00 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 80.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490033
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 12.80 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 51.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289556
1 mL ($43.13)
Human Serum - E74.3
- Donor:
- Gender: Male Age: 49 Ethnic group: European/Caucasian
- Diagnosed disease:
- C7.3
- Medication:
- L-thyroxine
- Parameter:
- Anti-Thyroglobulin (aTg / TAK)
Donor:
- Gender:
- Male
- Age:
- 49 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 35 kg/m²
- Blood type:
- Not specified
- Rhesus factor:
- not specified
- Weight:
- 120 kg
- Height:
- 186 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Other disorders of intestinal carbohydrate absorption [E74.3]
- hypothyroidism
- thyroid carcinoma [C7.3]
Medication:
- L-thyroxine (Dosages: 225µg)
- metformin (Dosages: 1000ms)
Therapy:
- radioiodine therapy
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual: negative
Quant: 0.23 kIU/L
Source: previous donation
|
< 115.00 kIU/L
|
Method: not specified System: Cobas Modular Roche |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344222
1 mL ($43.13)
Human Serum - Beta-CrossLaps (b-CTX), Capsule-react... - E55.9
- Donor:
- Gender: Female Age: 79
- Diagnosed disease:
- Q66.6 - Other congenital valgus deformities of feet
- Medication:
- Prolia
- Parameter:
- 25-Hydroxy-Vitamin D3 (Calcidiol) Anti-SS-A (Ro 52 and Ro 60) Anti-SS-B (La) Anti-Smith (Sm) Anti-U1 small nuclear ribonucleoprotein 70 kDa (U1-snRNP) Beta-CrossLaps (b-CTX) Bone alkaline phosphatase (BAP) Capsule-reactive protein (CRP) Complement C3 Complement C4 ...
Donor:
- Gender:
- Female
- Age:
- 79 Years
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Vitamin D deficiency, unspecified [E55.9]
- Lumbago with sciatica [M54.4]
- Postmenopausal osteoporosis [M81.00]
- Urinary tract infection, site not specified [N39.0]
- Other congenital valgus deformities of feet [Q66.6]
Medication:
- Prolia
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| 25-Hydroxy-Vitamin D3 (Calcidiol) |
Qual: negative
Quant: 30.90 ng/mL
Source: this donation
|
30.00 - 100 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Anti-SS-A (Ro 52 and Ro 60) |
Qual: negative
Quant: 1.10 U/mL
Source: this donation
|
< 15.00 U/mL
Remarks: borderline: 15,00 - 25,00 |
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-SS-B (La) |
Qual: negative
Quant: 2.10 U/mL
Source: this donation
|
< 15.00 U/mL
Remarks: borderline: 15,00 - 25,00 |
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-Smith (Sm) |
Qual: negative
Quant: 1.20 U/mL
Source: this donation
|
< 15.00 U/mL
Remarks: borderline: 15,00 - 25,00 |
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Anti-U1 small nuclear ribonucleoprotein 70 kDa (U1-snRNP) |
Qual: negative
Quant: 2.20 U/mL
Source: this donation
|
< 25.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Beta-CrossLaps (b-CTX) |
Qual: positive
Quant: 0.053 ng/mL
Source: this donation
|
0.142 - 1.351 ng/mL
Remarks: sex and age dependent |
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Bone alkaline phosphatase (BAP) |
Qual: negative
Quant: 20.70 µg/L
Source: this donation
|
5.50 - 27.10 µg/L
Remarks: sex and age dependent |
Method: EIA (Enzyme Immuno Assay) System: ISYS IDS |
| Capsule-reactive protein (CRP) |
Qual: positive
Quant: 6.75 mg/L
Source: this donation
|
0.00 - 3.00 mg/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C3 |
Qual: negative
Quant: 1.34 g/L
Source: this donation
|
0.90 - 1.80 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Complement C4 |
Qual: negative
Quant: 0.30 g/L
Source: this donation
|
0.10 - 0.40 g/L
|
Method: Nephelometry System: BN ProSpec Siemens |
| Osteocalcin |
Qual: positive
Quant: 8.10 ng/mL
Source: this donation
|
10.40 - 45.60 ng/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Parathyroid hormone (PTH) |
Qual: negative
Quant: 33.40 pg/mL
Source: this donation
|
11.50 - 78.40 pg/mL
|
Method: CLIA (Chemiluminescence Immuno Assay) System: ISYS IDS |
| Rheumatoid Factor (RF) IgA |
Qual: negative
Quant: 5.60 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgG |
Qual: negative
Quant: 7.80 U/mL
Source: this donation
|
< 20.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
| Rheumatoid Factor (RF) IgM |
Qual: negative
Quant: 4.10 IU/mL
Source: this donation
|
< 20.00 IU/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: BEP2000 Siemens |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH219175
1.1 mL ($142.31)
Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0
- Donor:
- Gender: Male Age: 51
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
- Medication:
- Euthyrox
- Parameter:
- Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Donor:
- Gender:
- Male
- Age:
- 51 Years
- BMI:
- 44.8 kg/m²
- Weight:
- 142 kg
- Height:
- 178 cm
Sample:
- Matrix:
- EDTA plasma
- Condition:
- icteric
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
- Euthyrox
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual: positive
Quant: 681.00 U/L
Source: this donation
|
40-129 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 12.30 mg/dl
Source: this donation
|
< 1 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 1000.00 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 1028.00 U/L
Source: this donation
|
Okt 71 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual: positive
Quant: 97.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual: positive
Quant: 81.00 U/L
Source: this donation
|
Okt 50 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100489733
Quant: 32.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual:
Quant: 11.30 g/dl
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: positive
Quant: 65.00 U/L
Source: this donation
|
13 - 60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Pancreatic Amylase |
Qual: negative
Quant: 22.00 U/L
Source: this donation
|
13 - 53 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308248
0.5 mL ($21.56)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Female Age: 74
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - T3, M1, stage IV, non-resectable (not specified)
- Medication:
- Dekristol
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
- Gender:
- Female
- Age:
- 74 Years
- BMI:
- 18 kg/m²
- Weight:
- 46 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - T3, M1, stage IV, non-resectable (not specified)
Medication:
- Dekristol (Dosages: 0.25mg)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 132.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: positive
Quant: 1.51 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 974.20 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 384.00 U/L
Source: this donation
|
< 36 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 45.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamic oxaloacetic transaminase (GOT / ASAT / AST) |
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490107
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: negative
Quant: 11.90 g/dl
Source: this donation
|
11.8 -15.8 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 59.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307906
0.9 mL ($38.81)
Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0
- Donor:
- Gender: Male Age: 62
- Diagnosed disease:
- C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
- Medication:
- Pantozol
- Parameter:
- Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
- Gender:
- Male
- Age:
- 62 Years
- BMI:
- 20.3 kg/m²
- Weight:
- 60 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Urine
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 1
Diseases:
- Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
- Pantozol
- Ramipril
- bisoprolol
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Alkaline Phosphatase (ALP) |
Qual:
Quant: 284.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Amylase |
Qual: I100490042
Quant: 40.00 U/L
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Bilirubin |
Qual: negative
Quant: 0.65 mg/dl
Source: this donation
|
< 1.2 mg/dl
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Cancer-Antigen 19-9 (CA 19-9) |
Qual: positive
Quant: 1803.00 U/mL
Source: this donation
|
< 27 U/mL
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) |
Qual: positive
Quant: 524.00 U/L
Source: this donation
|
< 61 U/L
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glutamate pyruvate transaminase (GPT / ALAT, ALT) |
Qual:
Quant: 142.00 U/L
Source: this donation
Remarks: abnormal |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual: I100490042
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range |
not specified not specified
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Hemoglobin (Hb) |
Qual: positive
Quant: 12.20 g/dl
Source: this donation
|
12.5-17.2 g/dl
Remarks: sex dependent |
Method: not specified System: not specified not specified Measured in: EDTA plasma |
| Lipase |
Qual: negative
Quant: 40.00 U/L
Source: this donation
|
13-60 U/L
|
Method: not specified System: not specified not specified Measured in: EDTA plasma |
Disclaimer
- All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
- Molecular genetic tests that establish the donor's identity are prohibited.
- Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
- An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289552
1 mL ($43.13)
